Filing Details
- Accession Number:
- 0000899243-21-015666
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-13 20:45:24
- Reporting Period:
- 2021-04-12
- Accepted Time:
- 2021-04-13 20:45:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1701541 | Black Diamond Therapeutics Inc. | BDTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1637054 | Brent Hatzis-Schoch | C/O Black Diamond Therapeutics, Inc. One Main Street, 10Th Floor Cambridge MA 02142 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-12 | 4,078 | $3.20 | 12,478 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-04-12 | 4,078 | $25.00 | 8,400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-04-12 | 179,915 | $0.00 | 4,078 | $3.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
164,552 | 2029-06-11 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020.
- 25% of the shares subject to this option vested and became exercisable on May 22, 2020, with the remainder vesting in 36 equal monthly installments thereafter.